Targifor, marca de suplementos vitamínicos pertencente a unidade de consumo na Sanofi (Consumer Healthcare), dá continuidade ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

Tanto Vale (VALE3) quanto Suzano (SUZB3) anunciaram novos CFOs na última sexta-feira (25). A mineradora nomeou Marcelo Bacci, anteriormente da produtora de papel e celulose, para o cargo de CFO ...

The former head of cancer drugmaker Seagen has joined a new startup involved in what’s recently become a competitive corner of oncology research. The startup, Ottimo Pharma, emerged from stealth ...

Third quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session. Friday October 25, 2024 14:00 - 15:30 CET ...

Bloomberg — A Suzano (SUZB3) avalia opções para uma expansão nos EUA que incluem a aquisição de um negócio de fabricação de papel de propriedade da holding do bilionário Robert Kraft, de acordo com ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

A temporada de balanços internacional contará com dados de Colgate-Palmovile, Matercard e Sanofi (EPA:SASY ... uma diminuição de 15% em relação ao mesmo período de 2023. Suzano (BVMF:SUZB3) — A Suzano ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...